OOMA insider filing: 7,335 shares set to sell on NYSE for $94.5K

Rhea-AI Filing Summary

Ooma, Inc. (OOMA) Form 144 reports a proposed sale of 7,335 shares of Common stock through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $94,518.81, and an approximate sale date of 09/04/2025. The filing shows those shares were acquired as restricted stock on 06/10/2025, 06/15/2025 and 09/01/2025 from the issuer. The filer disclosed prior sales in the past three months: 10,704 shares sold on 06/09/2025 generating $142,460.61 in gross proceeds.

The notice includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer and contains standard signature and legal attestations.

Insights

Securities Analyst

TL;DR: Proposed sale size is small relative to outstanding shares and appears routine rather than market-moving.

The Form 144 shows a planned sale of 7,335 common shares valued at $94,518.81 against 27,600,000 shares outstanding, representing a de minimis fraction of the outstanding float. Recent insider sales of 10,704 shares for $142,460.61 are disclosed, and the shares to be sold were issued as restricted stock by the issuer. From a market-impact perspective, these transactions are unlikely to affect trading or valuation materially, but they are relevant for monitoring insider liquidity and timing.

Corporate Governance Expert

TL;DR: Disclosure follows Rule 144 norms; filings indicate issuer-issued restricted stock and routine insider disposals.

The filing documents acquisitions of restricted stock on specific dates in 2025 and the intent to sell under Rule 144. The signer affirms no undisclosed material adverse information, and the broker is identified. These are standard governance disclosures that help maintain transparency about insider share movements; there is no indication of unusual governance events or compliance exceptions in the notice itself.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7335	94518.81	27600000	09/04/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/10/2025	Restricted Stock	Issuer			2020	06/10/2025	Not Applicable
Common	09/01/2025	Restricted Stock	Issuer			989	09/01/2025	Not Applicable
Common	06/15/2025	Restricted Stock	Issuer			4326	06/15/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
SHIGEYUKI HAMAMATSU 525 ALMANOR AVENUE SUITE 200 SUNNYVALE CA 94085	Common	06/09/2025	10704	142460.61

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does OOMA's Form 144 disclose about the planned sale?

The filing discloses a proposed sale of 7,335 common shares via Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $94,518.81 and an approximate sale date of 09/04/2025.

How many OOMA shares are outstanding according to the filing?

The Form 144 lists 27,600,000 shares outstanding for the issuer.

Were the shares to be sold acquired from the issuer or purchased on the market?

The shares were acquired as restricted stock from the issuer on specific dates in 2025 (06/10/2025, 06/15/2025 and 09/01/2025) as disclosed in the filing.

Has the filer sold issuer shares recently?

Yes; the filing reports a sale of 10,704 common shares on 06/09/2025 producing $142,460.61 in gross proceeds within the past three months.

Does the Form 144 indicate any undisclosed material adverse information about OOMA?

No. The person for whose account the securities are to be sold represents by signing the notice that they do not know of any material adverse information not publicly disclosed.